3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
Neoplasm Metastasis
9
Stomach Neoplasms
5
Endometrial Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Adenocarcinoma
3
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neoplasms
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Melanoma
1
Interventions
Temozolomide
23
Radiotherapy
10
Magnetic Resonance Spectroscopy
10
Radiation
8
Specimen Handling
7
Lomustine
4
Bevacizumab
4
Nivolumab
3
Biopsy
3
veliparib
2
trametinib
2
olaparib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
cemiplimab
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Photons
2
Palliative Care
2
Ipilimumab
2
D2C7-(scdsFv)-PE38KDEL
2
CTLA-4 Antigen
2
Aminolevulinic Acid
2
vocimagene amiretrorepvec
1
varlilumab
1
ulixertinib
1
tinostamustine
1
temsirolimus
1
senicapoc
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
trastuzumab deruxtecan
×
30 days
×
Clear all
No trials found.